Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers discuss HER2-low and HER2-zero in breast cancer

2.

A healthier lifestyle after bowel screening shown to prevent bowel cancer

3.

EMA Backs Breast Cancer SERD After FDA No Vote

4.

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

5.

United States Lung Cancer Screening Rates Remain Low. s. in particular in the South.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot